Brief: Abionyx Pharma: Cash Position Of EUR 2.9 Million As Of March 31
May 17 (Reuters) - Abionyx Pharma SA ABNX.PA :
* ABIONYX PHARMA PROVIDES AN UPDATE ON ITS ACTIVITY AND ITS
CASH
POSITION FOR THE FIRST QUARTER 2023
* CASH POSITION OF EUR 2.9 MILLION AS OF MARCH 31, 2023
* CONSOLIDATED QUARTERLY REVENUE OF EUR 1.1 MILLION
Source text for Eikon: ID:nBw9ZKmBva
Further company coverage: ABNX.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Abionyx Pharma SA
See all newsBrief: ABIONYX Pharma And OLON Enter Into Strategic Manufacturing Partnership
France's ABIONYX Pharma H1 net loss widens as financial expenses rise
Brief: ABIONYX Pharma H1 EBIT EUR -2.27 Million
Abionyx jumps as Stifel starts coverage with 'buy'
Cardiovascular drug developer ABIONYX Pharma's H1 revenue falls